Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
206 participants
OBSERVATIONAL
2014-08-31
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities
NCT02137785
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
NCT07144852
Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy
NCT02239679
Photodynamic Therapy With Levulan® +/- Topical Retinoid Pre-Treatment In The Treatment Of Actinic Keratoses
NCT01053000
Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)
NCT01458587
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ALA
Subjects who received ALA in CP0108
Aminolevulinic Acid (ALA)
Levulan PDT given in CP0108
BLU-U Blue Light Photodynamic Therapy Illuminator
PDT given in CP0108
Vehicle
Subjects who received Vehicle in CP0108
Topical Solution Vehicle
Vehicle PDT given in CP0108
BLU-U Blue Light Photodynamic Therapy Illuminator
PDT given in CP0108
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aminolevulinic Acid (ALA)
Levulan PDT given in CP0108
Topical Solution Vehicle
Vehicle PDT given in CP0108
BLU-U Blue Light Photodynamic Therapy Illuminator
PDT given in CP0108
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DUSA Pharmaceuticals, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stuart Marcus, MD, PhD
Role: STUDY_DIRECTOR
DUSA Pharmaceuticals, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center For Dermatology Clinical Research, Inc.
Fremont, California, United States
UCSD Dermatology
San Diego, California, United States
Center for Clinical and Cosmetic Research
Aventura, Florida, United States
MOORE Clinical Research, Inc
Brandon, Florida, United States
Spencer Clinical Services
St. Petersburg, Florida, United States
Altman Dermatology Associates
Arlington Heights, Illinois, United States
Shideler Clinical Research Center
Carmel, Indiana, United States
The Indiana Clinical Trials Center, PC
Plainfield, Indiana, United States
Minnesota Clinical Study Center
Fridley, Minnesota, United States
Oregon Dermatology and Research Center
Portland, Oregon, United States
J&S Studies, Inc
College Station, Texas, United States
Suzanne Bruce and Associates, P.A.,The Center for Skin Research
Houston, Texas, United States
Virginia Clinical Research, Inc.
Norfolk, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP0108A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.